MARKET

LUCD

LUCD

Lucid Diagnostics Inc.
NASDAQ
1.070
+0.020
+1.90%
After Hours: 1.089 +0.019 +1.79% 16:34 06/30 EDT
OPEN
1.050
PREV CLOSE
1.050
HIGH
1.070
LOW
1.040
VOLUME
1.05M
TURNOVER
--
52 WEEK HIGH
1.629
52 WEEK LOW
0.9000
MARKET CAP
217.28M
P/E (TTM)
-2.2849
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LUCD last week (0622-0626)?
Weekly Report · 1d ago
Lucid Diagnostics Shareholders Approve Stock Authorization Increase
TipRanks · 5d ago
Lucid Diagnostics shareholders approve charter amendment raising authorized common shares to 400 million
PUBT · 5d ago
Globus Medical (GMED) Surges 5.1%: Is This an Indication of Further Gains?
NASDAQ · 06/22 10:38
Weekly Report: what happened at LUCD last week (0615-0619)?
Weekly Report · 06/22 09:35
Weekly Report: what happened at LUCD last week (0608-0612)?
Weekly Report · 06/15 09:36
Lucid Diagnostics Misses On Revenue, But 2026 Growth Outlook Lights Up Bull Case
Benzinga · 06/08 15:25
Lucid Diagnostics Is Maintained at Buy by Ascendiant Capital
Dow Jones · 06/08 10:14
More
About LUCD
Lucid Diagnostics Inc. is a commercial-stage cancer prevention medical diagnostics company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company's products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. The Company is a subsidiary of PAVmed Inc.

Webull offers Lucid Diagnostics Inc stock information, including NASDAQ: LUCD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUCD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LUCD stock methods without spending real money on the virtual paper trading platform.